BiotechTube
Home/Thylacine Biosciences/Anne Moscona, MD
AM

Anne Moscona, MD

Inventor, Scientific Advisor

Thylacine Biosciences

Therapeutic Areas

Infectious DiseaseRespiratory Diseases

Thylacine Biosciences Pipeline

DrugIndicationPhase
Undisclosed Commercial Antiviral(s)Persistent endemic respiratory virusesPre-clinical
Undisclosed Biothreat Antiviral(s)High-consequence viral pathogens with pandemic potentialPre-clinical

Leadership Team at Thylacine Biosciences

MP
Matteo Porotto, PhD
Inventor, Scientific Advisor
EH
Elma Hawkins, PhD, MBA
Chairwoman of the Board
DG
Daniel Graifman, MBA
President
TM
Tom Monath, MD
Chief Medical Officer
View full Thylacine Biosciences profile